Methylamine → (5-Methylcarbamoyl-[1,3,4]oxadiazol-2-ylmethyl)carbamic acid tert-butyl ester
Reaction equation
C(O[C:4]([C:6]1[O:7][C:8]([CH2:11][NH:12][C:13]([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14])=[N:9][N:10]=1)=[O:5])C.[CH3:20][NH2:21]>C1COCC1>[C:16]([O:15][C:13](=[O:14])[NH:12][CH2:11][C:8]1[O:7][C:6]([C:4](=[O:5])[NH:21][CH3:20])=[N:10][N:9]=1)([CH3:17])([CH3:18])[CH3:19]Participants
4
Procedure
Prepared in an analogous fashion to Description 35 from 5-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-1,3,4-oxadiazole-2-carboxylic acid ethyl ester (prepared as described in JOC (1995), 60(10), 3112-20) (0.150 g) using 2.0M methylamine in THF.
Sources & evidence
- ORD record
- ord-1faecd064f4c494290368abf29dc8b0d
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07622464B2
Reaction notes
Loading…